Revvity | PKI - 债务利息支出

股票价格
86.77
每天变化
-0.38 -0.44%
每月一次
-1.22%
每年
-7.98%
Q2 预测
91.89


金融业
股票价格
USD
资产
USD 12.17B
现金及等价物
USD 919.86M
销售成本
USD 350.4M
流动资产
USD 2.24B
流动负债
USD 1.33B
债务
USD 3.37B
股息收益率
0.29
EBIT
USD 145.83M
EBITDA
USD 248.91M
员工
11K
EPS每股收益
USD 1.7
股本和储备
USD 7.38B
销售毛利
USD 421.66M
债务利息支出
USD 23.51M
利息收入
USD 0.4
贷款资金
USD 2.63B
市值
USD 10.68B
净收入
USD 98.36M
营业费用
USD 626.22M
营业利润
USD 145.83M
普通股股本
USD 113.38M
PE价格收益
49.87
税前利润
USD 55.68M
销售收入
USD 772.06M
销售和管理费用
USD 251.73M
股票
USD 379.5M
贸易债权人
USD 185.46M
应收帐款人
USD 744.67M


债务利息支出 更改 日
Agilent USD 25M 2M 2025-12
Align Technology USD 2M 660K 2023-03
Bio Techne USD 2.18M 173K 2025-06
Bio-Rad Laboratories USD 12.3M 100K 2025-09
Bruker USD 20M 4.3M 2025-09
Celltrion KRW 19B 1.96B 2025-06
Charles River Laboratories USD 23.78M 1.63M 2025-12
Cspc Pharmaceutical CNY 6.76M 3.43M 2025-12
Danaher USD 63M 8M 2026-03
Dentsply International USD 22M 1000K 2025-12
Deva Holding AS TRY 272.53M 69.04M 2023-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Divis Laboratories Ltd INR 60M 30M 2025-12
Edwards Lifesciences USD 35.9M 2.7M 2025-12
Illumina USD 25M 0 2025-09
Intuitive Surgical USD 20.11B 58.39B 2026-03
IQVIA Holdings USD 193M 4M 2025-12
Kangmei Pharma CNY 1.82M 150K 2025-09
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Laboratorios Farma EUR 699K 666.2K 2025-06
Laboratory Of America USD 55M 1000K 2025-12
Medical Developments International AUD 18K 3K 2025-06
Mesa Laboratories USD 3.02M 180K 2024-09
Mettler Toledo International USD 17.39M 307K 2025-12
Myriad Genetics USD 4.4M 600K 2025-12
Neuren Pharmaceuticals AUD 0 0 2024-06
OraSure Technologies 1.67M 1.13M 2025-12
Organigram Holdings CAD 179K 127K 2025-03
Ovoca Bio EUR 7K 6K 2022-06
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Pharma Mar EUR 117K 1.24M 2025-09
Qiagen NV USD 10.14M 1.92M 2025-12
Quest Diagnostics USD 69M 2M 2025-09
Quidel USD 5.68B 5.63B 2025-09
Repligen USD 5.5M 81K 2025-12
Revvity USD 23.51M 742K 2025-12
Sartorius EUR 49.5M 8.1M 2025-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Thermo Fisher Scientific USD 354M 11M 2026-03
Tilray USD 6.7M 2.73M 2025-06
Waters USD 8.62M 18.02M 2025-12
Zealand Pharma A/S 7.07M 74K 2025-12
Zz Pientze Pharmaceu CNY 46.05M 36.5M 2025-06